Swedish firm Recipharm has picked up 74 per cent stake in sterile injectables maker Nitin Lifesciences for Rs. 671 crore ($103 million) in an all cash deal..Veritas Legal acted for Recipharm with a team led by Partner Nandish Vyas along with Associates Natasha Sethna and Tejasvi Saxena..Khaitan & Co advised the promoters of Nitin Lifesciences with a team led by Partner Kalpana Unadkat along with Senior Associate Shweta Dwivedi and Associate Bidya Mohanty..Khaitan Partner Unadkat in the release commented,.“This transaction is another example of international corporates buying high-performing pharma assets, which further evidences buoyancy of the pharma sector in India”..This is the largest inbound deal in the sterile injectables space in the last two years, after the $1.75 billion acquisition of Strides Arcolab’s subsidiary Agila Specialities by Mylan in 2013.
Swedish firm Recipharm has picked up 74 per cent stake in sterile injectables maker Nitin Lifesciences for Rs. 671 crore ($103 million) in an all cash deal..Veritas Legal acted for Recipharm with a team led by Partner Nandish Vyas along with Associates Natasha Sethna and Tejasvi Saxena..Khaitan & Co advised the promoters of Nitin Lifesciences with a team led by Partner Kalpana Unadkat along with Senior Associate Shweta Dwivedi and Associate Bidya Mohanty..Khaitan Partner Unadkat in the release commented,.“This transaction is another example of international corporates buying high-performing pharma assets, which further evidences buoyancy of the pharma sector in India”..This is the largest inbound deal in the sterile injectables space in the last two years, after the $1.75 billion acquisition of Strides Arcolab’s subsidiary Agila Specialities by Mylan in 2013.
